Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

 1.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.15
  • 52 Week Low: 0.95
  • Currency: UK Pounds
  • Shares Issued: 135.47m
  • Volume: 195,426
  • Market Cap: £2.03m
  • RiskGrade: 504

Physiomics secures contract with University of Sheffield

By Iain Gilbert

Date: Monday 19 Feb 2024

LONDON (ShareCast) - (Sharecast News) - Data science firm Physiomics has been chosen by the University of Sheffield to support a grant-funded project focused on an insect model of cancer treatment.
Physiomics said on Monday that the contract was valued at £45,000 and will begin in the second half of the year. The group added that the work was in support of one of seven cancer-focussed projects recently announced by the University, all of which will be funded by Yorkshire Cancer Research.

The AIM-listed group added that the work follows on from a pilot project with the University, funded by UK Research and Innovation's Higher Education Innovation Funding scheme, with the project focussed on the development of an insect model of cancer that could be used to screen new drugs prior to pre-clinical testing in more traditional models of cancer and has a particular focus on the prediction of metastasis.

Physiomics' role will be to create mathematical models based on experimental data and to explore the relationship between the effect of drugs in these models, established models, and humans. Physiomics will also provide advice and guidance on the possible commercialisation of the technology.

As of 1010 GMT, Physiomics shares were up 3.7% at 1.40p.







Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Physiomics Market Data

Currency UK Pounds
Share Price 1.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.15
52 Week Low 0.95
Volume 195,426
Shares Issued 135.47m
Market Cap £2.03m
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.2% below the market average33.2% below the market average33.2% below the market average33.2% below the market average33.2% below the market average
41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average
Price Trend
50.17% below the market average50.17% below the market average50.17% below the market average50.17% below the market average50.17% below the market average
8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average
Income Not Available
Growth
58.44% below the market average58.44% below the market average58.44% below the market average58.44% below the market average58.44% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average

Physiomics Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
12:03 96,445 @ 1.55p
09:44 25,848 @ 1.55p
08:46 40,000 @ 1.44p
07:51 33,133 @ 1.57p

Physiomics Key Personnel

COO Christophe Chassagnole
CEO Peter Sargent

Top of Page